| Literature DB >> 30135564 |
Shi Chen1, Yingying Yang1, Yimin Qu2, Yun Zou2, Huijuan Zhu1, Hongbo Yang1, Fengying Gong1, Linjie Wang1, Yu Jiang3, Bill Q Lian4, Cynthia Liu5, Chengsheng Yan6, Jianqiang Li7, Qing Wang8, Shi-Kun Zhang9, Hui Pan10.
Abstract
No large population-based study has focused on both maternal paternal risk factors for low birthweight (LBW) in China. We aimed to identify parental risk factors associated with LBW.A population-based, retrospective cohort study was conducted on 202,725 singleton infants at 37-42 weeks. These term singleton newborns were classified as LBW with birthweight ≤2500 g(TLBW) and normal birthweight between 50th to 97th percentile (TNBW 50th-97th) according to Chinese singleton norms. Multiple logistic regression analyses were used to find those parental risk factors of LBW by comparing two groups. TLBW and TNBW(50th-97th) occupied 4.8% and 70.8% of the study population, respectively. Logistic regression showed a significant association with positive maternal hepatitis B surface antigen (RR = 1.979, P = 0.047), irregular folic acid intake (RR = 1.152, P = 0.003), paternal history of varicocele (RR = 2.404, P = 0.003) and female babies (RR = 1.072, P = 0.046). Maternal smoking, hypertension and history of stillbirth were found related to LBW but no statistically significant. Positive maternal hepatitis B surface antigen, irregular folic acid intake, paternal history of varicocele had a negative effect on birth weight. Measures are necessarily taken to avoid them to improve pregnancy outcomes. Further studies should be done to investigate each detailed risk factors on LBW.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30135564 PMCID: PMC6105589 DOI: 10.1038/s41598-018-30036-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The distribution of term babies among different birthweight groups and comparison of mean birthweight of 3 groups. TNBW = Term normal birthweight; TLBW = Term low birth weight; Tmacrosomia = Term macrosomia; Others included birthweight of infants between 2500 g to 50th.
The distribution of LBW and NBW(50th–97th) in univariate analysis.
| NBW(50th–97th) | LBW | T/χ2 | P | |
|---|---|---|---|---|
| Weight (♀) | 53.49 ± 7.24 | 53.15 ± 7.55 | 4.843 | <0.001 |
| Height (♀) | 159.25 ± 4.82 | 158.92 ± 4.86 | 7.425 | <0.001 |
| BMI (♀) | 27.104 | <0.001 | ||
| <18.5 | 17682 (12.8%) | 1327 (14.5%) | ||
| 18.5–24 (Ref.) | 105304 (76.1%) | 6774 (73.9%) | ||
| 24–28 | 12966 (9.4%) | 890 (9.7%) | ||
| 28–32 | 1863 (1.3%) | 136 (1.5%) | ||
| ≥32 | 555 (0.4%) | 39 (0.4%) | ||
| Age (♀) | 25.13 ± 3.88 | 25.21 ± 3.90 | −1.734 | 0.083 |
| Age (♂) | 27.23 ± 4.36 | 27.43 ± 4.42 | −4.059 | <0.001 |
| Height (♂) | 171.22 ± 5.14 | 170.89 ± 5.14 | 6.832 | <0.001 |
| Weight (♂) | 65.74 ± 9.14 | 65.40 ± 9.20 | 3.938 | <0.001 |
| BMI groups (♀) | 27.104 | <0.001 | ||
| BMI < 18.5 | 17682 (12.8%) | 1327 (14.5%) | ||
| BMI = 18.5–24 (Ref.) | 105304 (76.1%) | 6774 (73.9%) | ||
| BMI = 24–28 | 12966 (9.4%) | 890 (9.7%) | ||
| BMI = 28–32 | 1863 (1.3%) | 136 (1.5%) | ||
| BMI ≥ 32 | 555 (0.4%) | 39 (0.4%) | ||
| Gestational age | 39.25 ± 1.50 | 37.61 ± 4.12 | 46.378 | <0.001 |
| Maternal hypertension | 1.264 | 0.261 | ||
| No (Ref.) | 133947(97.7%) | 8847(97.5%) | ||
| Yes | 3222(2.3%) | 230 (2.5%) | ||
| History of stillbirth | 54.995 | <0.001 | ||
| No(Ref.) | 143567(99.9%) | 9665(99.8%) | ||
| Yes | 63(0.1%) | 22(0.2%) | ||
| Maternal smoking | 1.009 | 0.315 | ||
| No (Ref.) | 138276(99.7%) | 9184(99.6%) | ||
| Yes | 483 (0.3%) | 38(0.4%) | ||
| Gum bleeding (♀) | 1.082 | 0.298 | ||
| No(Ref.) | 131930 (95.5%) | 8733 (95.3%) | ||
| Yes | 6204 (4.5%) | 433 (4.7%) | ||
| Folic acid intake (♀) | 7.374 | 0.007 | ||
| Regular (Ref.) | 102962 (94.4%) | 6797 (93.6%) | ||
| Irregular | 6113 (5.6%) | 462 (6.4%) | ||
| WBC (♀) | 7.08 ± 3.30 | 7.18 ± 3.35 | −3.097 | 0.002 |
| Red blood cells (♀) | 6.328 | 0.042 | ||
| <3.5*1012/L | 10548 (7.7%) | 751 (8.1%) | ||
| 3.5–5.0*1012/L (Ref.) | 118488 (86.2%) | 7887 (85.3%) | ||
| >5.0*1012/L | 8351 (6.1%) | 606 (6.6%) | ||
| Hepatitis B surface antigen (♀) | 8.451 | 0.015 | ||
| Negative (Ref.) | 130299 (95.4%) | 8742 (94.8%) | ||
| Positive | 6263 (4.6%) | 470 (5.1%) | ||
| History of contraception (♀) | 4.328 | 0.037 | ||
| No (Ref.) | 110280 (79.8%) | 7238 (78.9%) | ||
| Yes | 27933 (20.2%) | 1937 (21.1%) | ||
| Paternal smoking | 0.608 | 0.436 | ||
| No (Ref.) | 90377 (67.6%) | 6010 (68.0%) | ||
| Yes | 43360 (32.4%) | 2381 (32.0%) | ||
| Paternal history of varicocele | 13.683 | 0.000 | ||
| No (Ref.) | 143554(99.9%) | 9673(99.9%) | ||
| Yes | 74(0.1%) | 14(0.1%) | ||
| Gender (infant) | 8.726 | 0.003 | ||
| Male (Ref.) | 73367(51.1%) | 4796(49.5%) | ||
| Female | 70263(48.9%) | 4887(50.5%) |
Factors found significant by univariate analysis.”♂” means man, “♀” means woman. “Ref.” means “Reference group”.
Figure 2Independent risk factors found in multiple logistic regression analysis. RR = Relative risk. Cl = Confidence interval. The vertical bar represented RR = 1 and horizontal lines represented the range of adjusted RR of each risk factors. The reference group were: No history of varicocele, having regular folic acid intake, negative hepatitis B surface antigen, maternal non-smoking, no history of stillbirth, baby sex = male; RR were adjusted by maternal age and educational level.
Figure 3Study profile.
Items included in our study.
| Items | Contents |
|---|---|
| Social demographics | Pregnancy age, height of parents, nationality, education level, employment type, infants’ gender and body weight |
| Illness and medical history | Paternal history of hypertension, diabetes mellitus, thyroid disorders, nephritis, heart disease, tuberculosis, hepatitis |
| Parental living habits and nutritional status | Parental smoking and drinking status, maternal intake of folic acid and the time and length of folic acid use, Paternal use of contraceptives |
| Parental psychological status before and during pregnancy | Life or work pressure, tensions in relationships with their colleagues and relatives, preparedness for pregnancy |
| Environmental risk factors exposure | Parental exposure to radiation, organic solvents, pesticides and pets before and during pregnancy |
| Parental reproductive health | Maternal history of adnexitis, presence of bacterium, trichomonas, chlamydia trachomatis, neisseria gonorrhoeae infection in maternal vaginal fluid, evidence of parental treponema pallidum antibodies, maternal infection of cytomegalovirus IgM and toxoplasma IgM, paternal history of mumps, orchitis, epididymitis and varicocele |
| Maternal abnormalities during pregnancy | Vaginal bleeding, fever, diarrhea and abdominal pain during pregnancy |
| Parental biological parameters | Maternal systolic and diastolic blood pressure; hemoglobin, red blood cell, platelet, white blood cell count, neutrophil ratio, blood glucose, alanine aminotransferase, creatinine, thyrotrophic hormone and hepatitis B surface antigen; paternal alanine aminotransferase, creatinine, and hepatitis B surface antigen |
Items included in our study. These items covered the maternal and paternal factors, including social demographics, living habits and nutrition, psychological status, environmental exposure risk factors, reproductive health, maternal abnormalities during pregnancy, and biological parameters, which were formulated by experts.
The assignment of numeric variables.
| Variable | Group | Assignment |
|---|---|---|
| Blood pressure (BP)(♀) | Normal | 0 |
| Systolic BP > 140 mmHg/diastolic BP > 90 mmHg | 1 | |
| BMI (♀) | BMI < 18.5 Kg/m2 | 0 |
| BMI ≥ 18.5 Kg/m2 and BMI < 24 Kg/m2 | 1 | |
| BMI ≥ 24 Kg/m2and BMI < 28Kg/m2 | 2 | |
| BMI ≥ 28 Kg/m2 and BMI < 32 Kg/m2 | 3 | |
| BMI ≥ 32 Kg/m2 | 4 | |
| Hemoglobin (♀) | 110–150 g/L | 0 |
| <110 g/L | 1 | |
| >150 g/L | 2 | |
| Red blood cells (♀) | 3.5–5.0*1012/L | 0 |
| <3.5*1012/L | 1 | |
| >5.0*1012/L | 2 | |
| Platelets (♀) | 100–300*109/L | 0 |
| <100*109/L | 1 | |
| >300*109/L | 2 | |
| Leukocyte (♀) | 4–10*109/L | 0 |
| <4*109/L | 1 | |
| >10*109/L | 2 | |
| Alanine (♀) | 10–40 U/L | 0 |
| <10 U/L | 1 | |
| >40 U/L | 2 | |
| Creatinine (♀) | 44–97μmol/L | 0 |
| <44μmol/L | 1 | |
| >97μmol/L | 2 | |
| Thyroid Stimulating Hormone (TSH) (♀) | 2–10mU/L | 0 |
| <2 mU/L | 1 | |
| >10 mU/L | 2 | |
| Percentage of neutrophils (♀) | 50–70% | 0 |
| <50% | 1 | |
| >70% | 2 | |
| Percentage of eosinophil granulocyte (♀) | 0.5–5% | 0 |
| <0.5% | 1 | |
| >5% | 2 | |
| Percentage of lymphocyte (♀) | 20–40% | 0 |
| <20% | 1 | |
| >40% | 2 | |
| Percentage of monocyte (♀) | 3–8% | 0 |
| <3% | 1 | |
| >8% | 2 |
Variables assigned to different groups in our study. Table 2 shows how the variables were assigned to groups. In the table, “♂” means man and “♀” means woman.